BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 26539557)

  • 1. Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.
    Hasan MS; Bergmeier LA; Petrushkin H; Fortune F
    J Immunol Res; 2015; 2015():705831. PubMed ID: 26539557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the pathogenesis of Behçet's disease.
    Pineton de Chambrun M; Wechsler B; Geri G; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Aug; 11(10):687-98. PubMed ID: 22197900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS).
    Freysdottir J; Lau S; Fortune F
    Clin Exp Immunol; 1999 Dec; 118(3):451-7. PubMed ID: 10594567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.
    Clemente A; Cambra A; Munoz-Saá I; Crespí C; Pallarés L; Juan A; Matamoros N; Julià MR
    Immunol Lett; 2010 Apr; 129(2):57-63. PubMed ID: 20167234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.
    Bank I; Duvdevani M; Livneh A
    J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of gamma delta T cells in the pathogenesis and diagnosis of Behçet's disease].
    Mörike EM
    Dtsch Med Wochenschr; 1996 May; 121(21):A7. PubMed ID: 8646969
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of regulatory receptors on γδ T cells and their cytokine production in Behcet's disease.
    Parlakgul G; Guney E; Erer B; Kılıcaslan Z; Direskeneli H; Gul A; Saruhan-Direskeneli G
    Arthritis Res Ther; 2013 Jan; 15(1):R15. PubMed ID: 23336215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.
    Suzuki Y; Hoshi K; Matsuda T; Mizushima Y
    J Rheumatol; 1992 Apr; 19(4):588-92. PubMed ID: 1534375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.
    Giza M; Koftori D; Chen L; Bowness P
    Clin Exp Immunol; 2018 Jan; 191(1):11-18. PubMed ID: 28898393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular and clinical evidence of vitamin D signaling as a modulator of the immune system: Role in Behçet's disease.
    Shirvani SS; Nouri M; Sakhinia E; Babaloo Z; Mohammadzaeh A; Alipour S; Jadideslam G; Khabbazi A
    Immunol Lett; 2019 Jun; 210():10-19. PubMed ID: 30935876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease.
    Hasan A; Fortune F; Wilson A; Warr K; Shinnick T; Mizushima Y; van der Zee R; Stanford MR; Sanderson J; Lehner T
    Lancet; 1996 Mar; 347(9004):789-94. PubMed ID: 8622334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
    Paul S; Lal G
    Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.
    Treusch M; Vonthein R; Baur M; Günaydin I; Koch S; Stübiger N; Eckstein AK; Peter HH; Ness T; Zierhut M; Kötter I
    Rheumatology (Oxford); 2004 Oct; 43(10):1275-82. PubMed ID: 15252211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51.
    Yasuoka H; Yamaguchi Y; Mizuki N; Nishida T; Kawakami Y; Kuwana M
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S59-63. PubMed ID: 19026117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.
    Freysdottir J; Hussain L; Farmer I; Lau SH; Fortune F
    Oral Dis; 2006 May; 12(3):271-7. PubMed ID: 16700735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-gammadelta receptor restriction in peripheral lymphocytes of patients with Behçet's disease.
    van Hagen PM; Hooijkaas H; Vd Beemd MW; Verjans G; Baarsma GS
    Adv Exp Med Biol; 2003; 528():267-8. PubMed ID: 12918704
    [No Abstract]   [Full Text] [Related]  

  • 17. IL-17A and IFN-γ are Up-regulated in CD4 and γδ T Cells in Active Behcet's Disease Patients.
    Abbasova V; Gül A; Saruhan-Direskeneli G
    Immunol Lett; 2022 Feb; 242():37-45. PubMed ID: 34838533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.
    Nguyen CT; Maverakis E; Eberl M; Adamopoulos IE
    Semin Immunopathol; 2019 Sep; 41(5):595-605. PubMed ID: 31506867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria.
    D'Ombrain MC; Hansen DS; Simpson KM; Schofield L
    Eur J Immunol; 2007 Jul; 37(7):1864-73. PubMed ID: 17557374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gammadelta T lymphocytes in the development of Behçet's disease.
    Yamashita N; Kaneoka H; Kaneko S; Takeno M; Oneda K; Koizumi H; Kogure M; Inaba G; Sakane T
    Clin Exp Immunol; 1997 Feb; 107(2):241-7. PubMed ID: 9030859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.